Abstract:Myasthenia gravis (MG) is a rare, treatable, antibody-mediated disease characterized by fatigable muscle weakness of extraocular muscles (EOMs) and non-ocular skeletal muscles. The antibodies are directed against muscle-endplate proteins, most frequently the acetylcholine receptor (AChR) alpha-subunit. Although most MG patients respond to immunosuppressive treatment, some individuals, frequently with African-genetic ancestry, develop treatment-resistant ophthalmoplegia (OP-MG). Although the underlying pathogenetic mechanisms of OP-MG remain unknown, experimental rodent models of MG showed upregulation of genes involved in oxidative metabolism in muscles. EOMs are highly dependent on oxidative metabolism. We opportunistically sampled EOM-tendons of two rare OP-MG patients (and non-MG controls) undergoing re-alignment surgery, and established ocular fibroblast cultures. Metabolic assays were performed on these live cells to assess real-time differences in energy metabolism. To study the cellular bioenergetic profiles in the context of MG, we exposed the cultures to homologous 5% MG sera for 24 h, vs. growth media, from two independent MG patients (with circulating AChR-antibodies) and five controls without MG, and estimated the fold change in oxygen consumption rates in response to three compounds which inhibit different mitochondrial chain complexes. Quantitative PCR (qPCR) was performed in cells before and after MG sera exposure, to assess transcript levels of mitochondrial genes, PDK4, ANGPTL4 and UCP3, which were altered in experimental MG. In response to the mitochondrial stressors, basal oxidative metabolism parameters were similar between OP-MG and control fibroblasts (p = 0.81). However, after exposure to MG sera, bioenergetic parameters (oxygen consumption rate as an indicator of oxidative phosphorylation; extracellular acidification rate as an indicator of glycolysis), were induced to higher levels in OP-MG fibroblasts compared to controls (2.6-fold vs 1.5-fold; p = 0.031) without evidence of mitochondrial insufficiency in the OP-MG ocular fibroblasts. In support of the bioenergetic responses to the same MG sera, gene transcripts of PDK4 and ANGPLT4 in ocular fibroblasts also showed significant upregulation (p ≤ 0.041), but similarly in OP-MG and control cases. Taken together we showed similar basal and metabolic adaptive responses after exposure to mitochondrial inhibitors in ocular fibroblasts derived from OP-MG cases and controls, although the OP-MG cells showed greater activation in response to MG conditions. These pilot results in orbital-derived tissues provide support for myasthenic-induced changes in cellular metabolism and evidence that orbital fibroblasts may be useful for dynamic bioenergetic assessments.

Analysis of Ptosis in Patients with Myasthenia Gravis Using a Video Eye-Measuring System

Jitter Analysis with Concentric Needle Electrodes in the Extensor Digitorum Communis for the Diagnosis of Myasthenia Gravis: a Pilot Study

Study on the diagnostic accuracy of palpebral fissure width in ice pack test to juvenile myasthenia gravis patients

Quantification of saccadic fatigability and diagnostic efficacy for myasthenia gravis

Palpebral Portion of the Orbicularis Oculi Muscle to Repetitive Nerve Stimulation Testing: A Potential Assessment Indicator in Patients with Generalized Myasthenia Gravis.

Optical Quality Assessment in Patients with Unilateral Congenital Ptosis: A Matched Case-Control Study

Investigation of the differential susceptibility of extraocular muscles in patients diagnosed with ocular myasthenia gravis based on the computerized diplopia test and the Ocular Motor Nerve Palsy Scale

Evaluation and validation of sustained upgaze combined with the ice-pack test for ocular myasthenia gravis in Asians

Sensitivity of Repetitive Nerve Stimulation in Different Facial Muscles in Patients with Ocular Myasthenia Gravis

Assessing facial weakness in myasthenia gravis with facial recognition software and deep learning

A Computer-Aided System for Ocular Myasthenia Gravis Diagnosis

Mitochondrial bioenergetics in ocular fibroblasts of two myasthenia gravis cases

A Novel Approach for Automated Eyelid Measurements in Blepharoptosis Using Digital Image Analysis

A Forward-Looking Exploration: Developing a Computer-aided Tool for Ocular Symptom Assessment in Myasthenia Gravis Based on Facial Images

Application of Digital Tools and Artificial Intelligence to the Myasthenia Gravis Core Examination

Application of digital tools and artificial intelligence in the Myasthenia Gravis Core Examination

Extraocular muscle volume on time-of-flight magnetic resonance angiography in patients with myasthenia gravis

Automated Measurement of Ocular Movements Using Deep Learning-Based Image Analysis

Evaluation of Optical Coherence Tomography Meibography in Patients With Obstructive Meibomian Gland Dysfunction

A Novel Meibomian Gland Morphology Analytic System Based On A Convolutional Neural Network

Facial and Emotion Recognition Deficits in Myasthenia Gravis